# Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

> **NCT07459309** · NA · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Liver Cancer (Primary and Metastatic)
- Liver Ablation

## Interventions

- **DEVICE:** Multimodal Tumor Thermal Ablation

## Key facts

- **NCT ID:** NCT07459309
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459309, "Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07459309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*